Total planned funding: $8,108,362
Clear active filters
USG Aggregated Agencies
Treatment
HTXD: Treatment: ARV Drugs
2015
2016
2017
2018
Allocations
Countries/Regions
Mozambique | $1,258,728 |
Tanzania | $1,048,960 |
Uganda | $928,326 |
South Africa | $847,918 |
Côte d'Ivoire | $799,305 |
Haiti | $486,770 |
Kenya | $440,309 |
Botswana | $380,019 |
Nigeria | $347,232 |
Democratic Republic of the Congo | $340,128 |
Rwanda | $302,912 |
Zambia | $241,068 |
South Sudan | $224,068 |
Eswatini | $125,949 |
Vietnam | $105,831 |
Guyana | $90,703 |
Malawi | $59,202 |
Burundi | $36,411 |
Cameroon | $26,354 |
Central Asia Region | $18,169 |
Lesotho | $0 |
Zimbabwe | $0 |
Namibia | $0 |
Ukraine | $0 |
Ethiopia | $0 |
Organizational Types
Own Agency | $8,108,362 |
Program Areas
Treatment | $8,108,362 |
Budget Codes
HTXD: Treatment: ARV Drugs | $8,108,362 |
Top Partner Programs
USG Aggregated Agencies:
$8,108,362
View countries